Can Benfotiamine Help Alzheimer’s Disease? This what scientists are trying to determine these days. According to Alzheimer's News Today, a large clinical trial has received $45 million in U.S. funding to evaluate the efficacy of benfotiamine — a lab-made precursor of thiamine or vitamin B1 — in slowing the cognitive decline of those with mildAlzheimer’s diseaseor mild cognitive impairment
Because benfotiamine is a dietary supplement the FDA only requires manufacturers and distributors to have credible evidence as to its safety. The FDA itself has not evaluated benfotiamine for safety or effectiveness. Benfotiamine therefore cannot be represented to diagnose, treat, cure or prevent any disease. For more information on this and related topics, please review our FAQ's on benfotiamine for more information. THE STATEMENTS MADE BY BENFOCOMPLETE HAVE NOT BEEN EVALUATED BY THE FDA (U.S. FOOD & DRUG ADMINISTRATION). OUR PRODUCTS ARE NOT INTENDED TO DIAGNOSE, CURE OR PREVENT ANY DISEASE. BENFOTIAMINE.NET, INC. IS NOT AFFILIATED WITH ANY OF THE STUDIES MENTIONED ON THE WEBSITE. THE TESTIMONIALS ON THIS WEBSITE ARE INDIVIDUAL CASES AND DO NOT GUARANTEE THAT YOU WILL GET THE SAME RESULTS.
BenfoComplete.com is a website of Benfotiamine.net Inc. Copyright ™ 2019 - BenfoComplete™ is a trademark of Benfotiamine.net Inc. - All Rights Reserved Worldwide